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ABSTRACT
Background To perform the first European overview of
educational inequalities in the use of blood pressure and
cholesterol screening.
Methods Data were obtained on the use of screening
services according to educational level from nationally
representative cross-sectional surveys in Belgium, Czech
Republic, Denmark, Estonia, Finland, Hungary, Italy,
Latvia and Lithuania. Screening rates were examined in
the preceding 12 months and 5 years, for respondents
35+ years (45+ for women). ORs comparing low- to
high-educated respondents were estimated using logistic
regression controlling for age.
Results Inequalities in cholesterol screening favouring
higher socioeconomic groups were demonstrated with
statistical significance among men in four countries,
whereby men with higher education were more likely to
receive screening, with 1.22 as the highest OR. Among
women, a similar pattern was found. Inequalities in blood
pressure screening were even smaller and less often
statistically significant. Hungary was the only country
with higher rates of both types of screening in the low-
educated group. In other countries, pro-high inequalities
were slightly increased after controlling for self-rated
health.
Conclusions All European countries in this study had
small educational inequalities in the utilisation of blood
pressure and cholesterol screening. These inequalities
are smaller than those previously observed in the USA.
Further comparative studies need to distinguish between
screening for preventive purposes and screening for
treatment and control.
INTRODUCTION
Large educational inequalities in cardiovascular
disease (CVD) mortality have been documented
across Europe.1 Narrowing these inequalities
requires an understanding of the role of access to
preventive services.2 Since early treatment of
hypertension and cholesterolemia may prevent or
slow cardiovascular complications, international
and national guidelines have all prescribed regular
screening.3
Although lower educational groups may be in
most need of screening, American studies reveal
that individuals of higher socioeconomic status are
more likely to receive testing for blood pressure or
cholesterol.4e6 Healthcare insurance and access to
a usual source of care are important contributors to
the likelihood of screening in the American context,
although they did not fully explain the socioeco-
nomic inequalities.3 6 No association has been
found between cholesterol screening and income or
education in Canada, where a national health
service exists.7 In another Canadian study on blood
pressure screening, those with lower education
were less likely to be screened and there was
a positive, but weaker, association for income.8
Much less research on socioeconomic inequalities
in blood pressure and cholesterol screening has been
conducted in Europe than in North America. In
Belgium, small socioeconomic inequalities,
according to Lorant et al,9 were found for choles-
terol screening, with people in the two lowest
income quintiles being less likely to receive
screening (ORs of 0.7 and 0.8, respectively). A
starker gradient was found in Spain, where the
likelihood of cholesterol screening was reduced
with decreasing education.10 Another Spanish
study found that lower occupational classes less
often received blood pressure screening.11 In Italy,
high-socioeconomic groups were found to be more
likely to have their blood pressure and cholesterol
checked, with the largest inequalities observed
among men in relation to education level.12
The present study is the ﬁrst to assess inequalities
in cardiovascular preventive services from a broader
European perspective. Its speciﬁc aim was to assess
the direction and magnitude of educational
inequalities in the use of screening for hypertension
and cholesterolemia in nine European countries. A
generalised pattern of small inequalities might
perhaps be expected in European healthcare systems,
given the relatively small levels of inequalities in
access to primary care.13 Systems with nationalised
healthcare and/or universal insurance, such as in
Europe, are generally designed to reduce adminis-
trative, geographical and ﬁnancial barriers. At the
same time, preventive services are organised differ-
ently in different countries, which could inﬂuence
the magnitude of equality in their use.2
METHODS
Study population
Data were obtained on cholesterol and blood pres-
sure screening according to educational level from
nationally representative cross-sectional surveys of
individuals aged 16 years and older in the following
European countries: Belgium, Czech Republic,
Denmark, Estonia, Finland, Hungary, Italy, Latvia
and Lithuania. There is no upper age limit to those
surveyed in most countries, but Estonia, Latvia,
Finland and Lithuania have an upper age limit of 64.
Further details on the surveys are given elsewhere.1
This study relied on micro-data ﬁles constructed
on the basis of national data ﬁles. These ﬁles were
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created in accordance with an extensive set of detailed speciﬁ-
cations to enhance intersurvey comparability. This study did not
need ethics approval, as only anonymised micro-data available at
national statistical ofﬁces were used. Table 1 presents the
composition of the study population.
Measures
Education level was harmonised between the different countries
on the basis of the International Standard Classiﬁcation of
Education. The national codes were classiﬁed into four cate-
gories of the International Standard Classiﬁcation of Education
scheme and later dichotomised into ‘high’ and ‘low’ education.
Low education referred to no completed education, only primary
education or lower secondary education (up to approximately
9 years). Higher education included upper secondary, post-
secondary non-tertiary and tertiary education.
The simple distinction between low and high education does
not take into account differences within these two broad groups.
Furthermore, the meaning of ‘low’ and ‘high’ varies between
European countries, partly because of differences in the educa-
tional systems. However, a more sophisticated measure of
educational inequalities, the Relative Index of Inequality,1
generated similar patterns to those reported in the Results
section below.
The information on blood pressure screening was derived
from survey questions such as, “When was the last time that
you had your blood pressure checked?” For cholesterol screening,
respondents were asked questions such as, “When was the last
time that you had your cholesterol checked?” Survey questions
were phrased similarly, with minor differences not expected to
affect the comparability of estimates between countries.
Responses to these questions were categorised in the same
way among the countries, using three classes: (1) screening
performed for the last time within the last 12 months; (2) longer
than 12 months ago, but within the last 5 years and (3) last time
>5 years ago or never. In Italy and the Czech Republic, the recall
period is only 12 months. In Belgium, only data for the 5-year
recall period are available. In Denmark, the extended recall
period referred to the last 3 years, instead of the last 5 years.
The variable age refers to the age of the respondent at the time
of the survey, wherein age is grouped in 5-year intervals.
Screening rates were examined among the general population,
which includes individuals aged 16 years and older, as well as
women aged 45 years and over and men aged 35 years and over.
These age groups comprise the recommended target groups
according to 1998 recommendations of a number of European
Societies, which were the most recent version at the time of the
surveys.3
The different target age groups for men and women led to the
decision to present the data separately for men and women. In
addition, previous studies have found gender differences in the
receipt of preventive services.14
As the use of preventive services may be inﬂuenced by the
prevalence of health problems, socioeconomic inequalities may
contribute to inequalities in screening, secondary to their effect
on inequalities in health. To evaluate the possible role of health,
each respondent’s self-rated health was assessed. Respondents’
general assessment of health was assessed by questions similar
to, “How do you judge your general state of health?” The most
important difference was in the wording of the answer cate-
gories, with some questions starting with ‘excellent’, while
others started with ‘very good’. Other answer categories were
‘good, fair, poor, very poor ’.
No internationally comparable data were available for control
variables, with the exception of smoking, body mass index and
self-reported diabetes. Control for these factors did not
substantially change the results as presented below. In order to
maintain a relatively simple model, a decision was made to
present results only controlled for age and self-rated health.
Statistical analyses
Analyses were conducted for each country and gender sepa-
rately. The percentage of the population screened in both the
lowest and the highest educational level was computed. Age-
standardised rates in 5-year intervals were calculated using direct
method with the European Standard Population as the reference
population.
The association between education and screening outcomes
was measured using ORs and their 95% CIs on SPSS version
15.0.1. Logistic regression was applied in two steps. First, control
was made for 5-year age group. In a second step, control was
made for both age and self-rated health. Self-rated health was
introduced into the model as a dichotomous variable (good or
very good health vs poorer health), as more detailed control for
this variable yielded results similar to those reported below.
RESULTS
Table 2 presents the percent distributions of cholesterol
screening by education level, stratiﬁed by gender. Screening rates
tend to be slightly greater among women than among men in
some countries. Differences in overall screening between coun-
tries are notable, with only Italy, Finland and the Czech
Republic achieving screening rates of >50% in the 12-month
recall period. Screening rates are approximately 50% and are
expectedly higher when the recall period is extended to 5 years.
Overall, educational differences in screening rates were small.
Table 3 shows OR for cholesterol screening among men over
5-year and 12-month recall periods. ORs higher than 1.00 imply
higher screening rates for those with high education. Over
a 5-year recall period, inequalities in cholesterol screening could
Table 1 Sample composition
Country Total number respondents Non-response rate (%) Years covered by surveys Mean age % Men % With low education
Belgium 18 481 41.5 1997/2001 46.9 48.5 41.0
Czech Republic 2476 29.3 2002 46.0 47.2 56.5
Denmark 16 690 25.8 2000 46.5 49.1 26.4
Estonia 4376 33.0/38.0 2002/2004 39.8 42.3 47.9
Finland 20 371 28.0e35.0 1994/1996/1998/2000/2002/2004 40.5 46.4 23.7
Hungary 10 532 21.0/28.0 2000/2003 46.4 47.9 46.7
Italy 167 618 13.4 1999/2000 47.0 48.1 62.9
Latvia 8488 20.0e40.0 1998/2000/2002/2004 39.5 43.5 44.3
Lithuania 11 647 28.0e39.0 1994/1996/1998/2000/2002/2004 41.2 44.1 40.5
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be demonstrated with statistical signiﬁcance for Belgium,
Denmark, Finland and Hungary, with OR ranging from 1.10
(95% CI 1.03 to 1.18) in Belgium to 1.21 (95% CI 1.07 to 1.36) in
Denmark. In these countries, men with higher education were
more likely to be screened. When the recall period was truncated
at 12 months, inequalities remained minimal and were statisti-
cally signiﬁcant only in Italy (OR¼1.10, 95% CI 1.07 to 1.14),
Denmark (OR¼1.22, 95% CI 1.05 to 1.41) and Finland
(OR¼1.22, 95% CI 1.09 to 1.37). In Hungary, the pattern of
inequalities reversed and the OR jumped from 0.72 (95% CI 0.65
to 0.79) to 1.15 (95% CI 1.10 to 1.20) for the 12-month recall
period. When controlling for self-rated health, slight increases in
inequalities were observed in Italy (OR¼1.14, 95% CI 1.11 to
1.18), Denmark (OR¼1.30, 95% CI 1.12 to 1.50) and Latvia
(OR¼1.26, 95% CI 1.02 to 1.55), while inequalities elsewhere
changed little. Controlling for self-rated health eliminated the
statistically signiﬁcant associations in Hungary.
The results for cholesterol screening in women are presented in
table 3. Inequalities were markedly smaller in women compared
with men. The reverse pattern of inequalities observed in
Hungary in men was not observed among Hungarian women.
Over both 5-year and a 12-month periods, statistically signiﬁcant
inequalities were found only in Finland (OR¼1.15, 95% CI 1.02
to 1.30), whereby the higher socioeconomic groups received
greater screening. After controlling for self-rated health, inequal-
ities became statistically signiﬁcant in Italy (OR¼1.07, 95% CI
1.03 to 1.11) and in Hungary (OR¼1.22, 95% CI 1.12 to 1.34).
Turning to blood pressure screening, table 4 shows absolute
prevalence rates for men and women over both a 12-month and
a 5-year time span. Overall, screening rates of over 70% have
been achieved in men in all countries, with Belgium, Estonia,
Finland, Italy and Hungary achieving screening rates of over
90% among both educational groups over a 5-year period.
Women achieved slightly higher rates over both 12-month and
Table 2 Age-standardised rates of cholesterol screening utilisation by country, sex and educational level (educ.) in target population group*
Country
Men Women
12-month cholesterol
screening 5-year cholesterol screeningy
12-month cholesterol
screening 5-year cholesterol screening
High Educ. Low Educ. High Educ. Low Educ. High Educ. Low Educ. High Educ. Low Educ.
Belgium 73.7 71.2 92.2 96.7
Czech Republic 46.4 50.7 58.9 59.3
Denmark 21.6 19.3 33.3z 29.2z 17.3 21.0 28.9z 30.5z
Estonia 42.0 40.0 64.2 59.7 45.8 48.7 70.5 69.1
Finland 53.1 48.9 78.1 74.5 58.8 54.1 81.1 77.2
Hungary 10.5 14.9 72.5 66.4 17.8 17.9 80.6 74.9
Italy 50.6 52.7 53.9 59.4
Latvia 22.8 21.7 33.5 33.4 29.7 30.5 44.5 44.4
Lithuania 27.0 27.6 43.0 39.7 30.5 36.2 43.5 50.5
*Target population group made up of women 45+ and men 35+.
yScreening performed for the last time longer than 12 months ago, but within the last 5 years.
zBased on 3-year recall period.
Table 3 OR (95% CI)* comparing prevalence of cholesterol screening among low-educated
to high-educated persons
Country
5-year period,
OR (95% CI)
12-month period,
OR (CI 95%)
12-month period, controlling for
self-rated health, OR (95% CI)
A. Men
Belgium 1.10 (1.03 to 1.18)
Czech Republic 1.15 (0.92 to 1.42) 1.19 (0.96 to 1.48)
Denmark 1.21 (1.07 to 1.36)y 1.22 (1.05 to 1.41) 1.30 (1.12 to 1.50)
Estonia 1.10 (0.92 to 1.32) 1.10 (0.88 to 1.37) 1.13 (0.91 to 1.41)
Finland 1.12 (1.02 to 1.23) 1.22 (1.09 to 1.37) 1.23 (1.09 to 1.38)
Hungary 1.15 (1.10 to 1.20) 0.72 (0.65 to 0.79) 0.97 (0.88 to 1.07)
Italy 1.10 (1.07 to 1.14) 1.14 (1.11 to 1.18)
Latvia 1.07 (0.91 to 1.27) 1.17 (0.95 to 1.44) 1.26 (1.02 to 1.55)
Lithuania 1.12 (0.98 to 1.29) 1.03 (0.87 to 1.22) 1.11 (0.93 to 1.31)
B. Women
Belgium 1.08 (1.00 to 1.16)
Czech Republic 1.02 (0.82 to 1.26) 1.04 (0.84 to 1.29)
Denmark 0.89 (0.76 to 1.04) 0.89 (0.76 to 1.04) 1.11 (0.98 to 1.25)
Estonia 0.96 (0.79 to 1.16) 0.96 (0.79 to 1.16) 1.00 (0.82 to 1.21)
Finland 1.15 (1.02 to 1.30) 1.15 (1.02 to 1.30) 1.00 (0.86 to 1.17)
Hungary 1.11 (1.07 to 1.16) 0.95 (0.87 to 1.04) 1.22 (1.12 to 1.34)
Italy 1.03 (0.99 to 1.07) 1.07 (1.03 to 1.11)
Latvia 1.02 (0.85 to 1.21) 1.02 (0.85 to 1.21) 1.08 (0.91 to 1.29)
Lithuania 0.92 (0.78 to 1.08) 0.92 (0.78 to 1.08) 1.02 (0.86 to 1.20)
*Estimated with control for age (in all columns) and self-assessed health (in the last column).
yBased on 3-year recall period.
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5-year recall periods. Overall, rates between educational groups
are quite comparable.
Results of the logistic regression for blood pressure screening
in men are presented in table 5. No statistically signiﬁcant
inequalities were observed in screening over the 5-year recall
period. Over the 12-month period, small inequalities with OR
>1 were demonstrated with statistical signiﬁcance in Italy
(OR¼1.10, 95% CI 1.06 to 1.13), Lithuania (OR¼1.10, 95% CI
1.00 to 1.21) and Finland (OR¼1.15, 95% CI 1.04 to 1.26). Here,
too, Hungary remained an outlier, where those with low
education were more likely to receive screening (OR¼0.62, 95%
CI 0.58 to 0.67). About half of this inverse relationship could be
explained by controlling for self-rated health (OR¼0.81, 95% CI
0.75 to 0.88). Controlling for self-rated health revealed slightly
elevated inequalities in Italy, Latvia and Lithuania, where lower
socioeconomic groups were less likely to be screened.
Table 5 presents the ORs for blood pressure screening in
women. For the 5-year recall period, no inequalities could be
demonstrated. All ORs are within a narrow range (1.00e1.05). For
the 12-month recall period, inverse inequalities with OR <1.00
were found in Hungary (OR¼0.78, 95% CI 0.73 to 0.84). Most
other countries showed small inequalities in screening favouring
higher socioeconomic groups over the 12-month recall period.
After controlling for self-rated health, the OR for some countries
became statistically signiﬁcant. In Denmark, Latvia and Lithuania,
the odds of a higher educated woman receiving screening were
found to be 1.11 or 1.12, after controlling for self-rated health.
DISCUSSION
This study yielded a generally positive view of the distribution
of cardiovascular preventive screening in nine European coun-
tries, with representation from both Eastern and Western
Europe. Socioeconomic inequalities in screening for both
hypertension and cholesterolemia were found to be generally
small. The use of screening services tended to be somewhat
higher among respondents with high education. Slightly greater
inequalities favouring the higher socioeconomic groups were
found in cholesterol than in blood pressure screening and greater
Table 4 Age-standardised rates of blood pressure screening utilisation by country, sex and educational level (educ.) in target population group*
Country
Men Women
12-month blood pressure
screening
5-year blood pressure
screening
12-month blood pressure
screening
5-year blood pressure
screening
High Educ. Low Educ. High Educ. Low Educ. High Educ. Low Educ. High Educ. Low Educ.
Belgium 92.7 92.9 96.6 96.7
Czech Republic 76.0 76.3 89.8 81.4
Denmark 48.6 52.3 72.3y 69.5y 63.5 59.6 81.4y 80.6y
Estonia 75.5 69.9 92.4 95.3 83.1 82.7 97.3 97.0
Finland 77.7 72.2 94.6 95.8 84.7 88.3 97.3 93.3
Hungary 25.9 16.2 92.2 92.9 29.4 23.5 95.9 96.0
Italy 56.2 60.5 68.8 62.2
Latvia 59.5 56.5 81.6 84.6 72.1 78.8 88.5 92.7
Lithuania 60.6 64.8 82.8 86.4 75.6 80.9 90.4 94.1
*Target population group made up of women 45+ and men 35+.
yBased on 3-year recall period.
Table 5 OR (95%CI)* comparing prevalence of blood pressure screening among low-educated
to high-educated persons
Country
5-year period,
OR (95% CI)
12-month period,
OR (CI 95%)
12-month period, controlling for
self-rated health, OR (95% CI)
A. Men
Belgium 1.02 (0.96 to 1.08)
Czech Republic 1.02 (0.86 to 1.21) 1.05 (0.88 to 1.25)
Denmark 1.02 (0.95 to 1.10)y 1.04 (0.95 to 1.13) 1.08 (0.99 to 1.18)
Estonia 1.04 (0.91 to 1.19) 1.09 (0.94 to 1.27) 1.11 (0.95 to 1.29)
Finland 1.02 (0.94 to 1.11) 1.15 (1.04 to 1.26) 1.15 (1.05 to 1.27)
Hungary 1.02 (0.99 to 1.05) 0.62 (0.58 to 0.67) 0.81 (0.75 to 0.88)
Italy 1.10 (1.06 to 1.13) 1.13 (1.10 to 1.17)
Latvia 1.04 (0.94 to 1.15) 1.10 (0.98 to 1.24) 1.13 (1.00 to 1.27)
Lithuania 1.05 (0.97 to 1.13) 1.10 (1.00 to 1.21) 1.13 (1.03 to 1.24)
B. Women
Belgium 1.01 (0.95 to 1.08)
Czech Republic 0.94 (0.79 to 1.12) 0.97 (0.81 to 1.17)
Denmark 1.05 (0.97 to 1.12)y 1.05 (0.97 to 1.14) 1.11 (1.02 to 1.20)
Estonia 1.00 (0.88 to 1.14) 1.01 (0.88 to 1.16) 1.04 (0.90 to 1.20)
Finland 1.00 (0.92 to 1.10) 1.06 (0.96 to 1.17) 1.07 (0.97 to 1.18)
Hungary 1.01 (0.97 to 1.05) 0.78 (0.73 to 0.84) 0.99 (0.92 to 1.07)
Italy 1.02 (0.98 to 1.06) 1.05 (1.01 to 1.09)
Latvia 1.04 (0.95 to 1.15) 1.10 (0.99 to 1.22) 1.12 (1.01 to 1.25)
Lithuania 1.04 (0.96 to 1.13) 1.08 (0.99 to 1.18) 1.12 (1.02 to 1.23)
*Estimated with control for age (in all columns) and self-assessed health (in the last column).
yBased on 3-year recall period.
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inequalities were observed among men than among women.
These inequalities were slightly more pronounced when
inequalities in general health were controlled.
The available data had some limitations. First, international
differences in data collection methods may have affected the
comparability of estimates for different countries. However,
small variations between countries in the magnitude of
inequality estimates suggest that any such differences in data
collection methods did not affect the results in a meaningful
way.
A second potential limitation is that non-response rates,
which ranged from 13% to 42% (table 1), could have biased
inequality. However, even if this bias was present, it is unlikely
to explain the small magnitude of inequalities observed, as large
inequalities were observed with the same data source for many
other health outcomes.1
Third, for the sake of brevity and international comparability,
educational levels were grouped into two broad categories. Using
a more reﬁned educational classiﬁcation, slightly larger educa-
tional differences in screening rates were observed (results not
shown).
Hungary was the only country where those with lower
education were more likely to have received screening in the past
12 months. This may be attributed to the effect of general
health: screening rates are higher among those with poorer
health, and poor health is more common among lower socio-
economic groups. Furthermore, at the time of the data collec-
tion, Hungary was undergoing drastic political and economic
changes, which may have undermined the general health of
lower socioeconomic groups in particular.15 This may also
account for the relatively large inequalities in cardiovascular
mortality in Hungary, compared with most other European
countries.1
In this study, no distinction could be made between screening
for preventive purposes and the measurement of blood pressure
and cholesterol in patients with CVD. Since CVD is more
prevalent among lower socioeconomic groups,16 measurements
for treatment and control are likely to be more prevalent among
these groups. If so, the results in this study may have concealed
inequalities in the reverse direction in measurements undertaken
for preventive purposes.
On a related point, inequalities in the use of preventive
healthcare were assessed without taking into account inequal-
ities in need. This approach may be justiﬁed on the grounds that,
according to international guidelines, all men and women at
speciﬁc ages should be regularly screened for cholesterolemia and
hypertension.3 Nevertheless, if lower socioeconomic groups are
at higher risk for developing these conditions, one might argue
that preventive services should be used more frequently by these
groups. Thus, despite the small ‘inequalities’ observed, the
situation may be less favourable in terms of ‘inequities’, that is,
after adjusting for need.9 In a recent Italian study, larger
educational inequalities were observed for cholesterol screening,
with ORs ranging from about 1.15 to 1.63, after controlling for
self-reports of hypertension, diabetes, smoking status and body
mass index.12 The ﬁnding in this study that the small inequal-
ities were slightly widened after controlling for general health
supports this possibility. Therefore, the possibility cannot be
excluded that detailed control for the occurrence and severity of
CVD would have shown larger inequalities, disadvantaging the
lower socioeconomic groups.
Interestingly, Finland, a northern European country with
universal access to healthcare services, had the highest rates
of inequalities in blood pressure and cholesterol screening.
However, in the 1990s, equal access to services among different
regions and different socioeconomic groups in that country
was adversely affected by government cuts to municipal
subsidies.17 18 Decentralisation of health service funding at that
time made individual municipalities responsible for funding
their health services through local taxation, perhaps thereby
increasing the risk of social and geographic inequalities in care.
American studies that have assessed educational disparities in
blood pressure screening report that the odds of being screened
over a 5-year period for higher educated people, compared with
lower educated, are as high as 2.82 (95% CI 1.57 to 5.07).19 In
addition, inequalities by race, insurance status and having
regular access to primary care have been documented exten-
sively. Inequalities in cholesterol screening are similarly striking,
as people with higher education have 2.11 (95% CI 1.31 to 3.40)
times higher odds of being screened.19 20 While it is not possible
to compare directly the inequality measures reported in different
studies, the education-based disparity in European screening
rates seems to be at similar levels to those in Canada and smaller
than in the USA.
Despite the greater equality, overall prevalence rates of
screening are much lower in European countries (and in Canada)
than in the USA (see tables 2 and 4). A main challenge for
European countries is to increase national rates of preventive
screening up to the levels recommended by the European Joint
Task Force, without increasing socioeconomic disparities.3
The relatively small socioeconomic disparity in screening in
European countries suggests that low education is not neces-
sarily a barrier. The larger inequalities in cardiovascular screening
in the USA suggest that the structure of the healthcare system,
rather than personal attributes of individuals, may be of key
importance. A US study suggested that higher screening
utilisation by people with higher education was related to their
greater access to health insurance reimbursement, and conse-
quently, usual care.19 Compared with the USA, European
countries have achieved greater equality in access to healthcare,
in part due to less variability in insurance status and user fees.21
For example, general practitioners’ services are universally
What is already known on this subject
< Although American studies have revealed large socioeco-
nomic inequalities in access to blood pressure and cholesterol
screening, much less is known about access to these
preventive services in Europe.
< The present study is the first to examine educational
inequalities in the use of screening for hypertension and
cholesterolemia from a broad European perspective
What this study adds
< This study found overall low rates of inequalities in screening,
although the use of screening services was somewhat higher
among respondents with high education, particularly when
inequalities in general health were controlled.
< The evidence suggests that the size of the inequalities mostly
depends on the structure of the healthcare system and on
service delivery.
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accessible and relatively often used by lower socioeconomic
groups in Europe.2
Different patterns of inequalities have been observed in
Europe for breast and cervical cancer screening. Pro-rich
inequalities, in which higher socioeconomic groups have greater
access to screening, have been observed in several European
countries for both types of cancer screening.2 These larger
inequalities might be due to a larger effect of patient-related
demand in the case of screening for cancer. However, while pro-
rich inequalities in breast cancer screening were large in Euro-
pean countries with opportunistic screening, these inequalities
were small or even absent in countries where pro-active national
screening programmes were available.22 This suggested that
supply factors, such as the way screening services are delivered,
play a key role.23
To conclude, all European countries in this overview have
small inequalities in the utilisation of blood pressure and
cholesterol screening. Comparisons to the USA suggest that the
size of inequalities mostly depends on the structure of the
healthcare system and on service delivery. Small levels of
inequality in screening are important in reducing CVD across all
socioeconomic groups. However, screening for secondary
prevention is only one step in the sequence of events needed to
reduce morbidity and mortality. National primary prevention
strategies to address obesity, living conditions and physical
ﬁtness are equally important goals.
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